Previous Page  6 / 11 Next Page
Information
Show Menu
Previous Page 6 / 11 Next Page
Page Background

Page 56

conferenceseries

.com

10

th

International Conference on

February 22-23, 2018 | Paris, France

Vascular Dementia

Volume 8

Journal of Alzheimers Disease & Parkinsonism

ISSN: 2161-0460

Vascular Dementia 2018

February 22-23, 2018

Exploring links between the microbiome and dementia

Deborah Shoemark

University of Bristol, UK

O

ur microbiome composition likely influences health and how well we age. Here we provide a background describing the

links between oral bacteria and sporadic Alzheimer’s disease. We present our data from Next Generation Sequencing

(NGS) comparing bacterial reads from AD and cognitively normal temporal cortex. Immunosenescence results in waning

targeted immune responses and increased reliance on innate immunity. As a result, bacterial and inflammatory cytokine load,

particularly in conjunction with e.g. poor oral hygiene, rise with age and many neurodegenerative diseases are associated

with inflammation. Gum disease increases periodontal pocket depth and shifts the balance of the oral microbiome towards a

more anaerobic population, capable of eliciting greater TNF-alpha release from buccal cells lining the mouth. High levels of

pro-inflammatory cytokines e.g. TNF-alpha, compromise the integrity of the normally protective blood brain barrier. Bacteria

escaping the mouth and gut are more likely to evade targeted immune responses, so low levels in the circulation fail to elicit

classic signs of systemic infection, but instead contribute to local or generalized inflammation. Sensitive techniques such as

NGS, now suggest biofilm can form on many surfaces, including blood vessels. Under some circumstances this may provide an

environment that allows harmful or anaerobic bacteria, otherwise unable to adhere or survive in isolation, to thrive. Some oral

bacteria are also known to subvert otherwise benign biofilm to an aggressively inflammatory form. A better understanding of

the host/microbiome interplay in neurological disease may reveal opportunities for new therapeutic and preventive strategies.

J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C1-037